Medina International Holdings, Inc.
Executive Summary (OTC:BB:MIHI)
MIHI Security Details
| ||Market Value1 ||$5,468,786 ||a/o Jun 14, 2016 |
| ||Authorized Shares ||500,000,000 ||a/o May 16, 2016 |
| ||Outstanding Shares ||56,090,117 ||a/o Aug 25, 2013 |
| ||-Restricted ||Not Available |
| ||-Unrestricted ||Not Available |
| ||Held at DTC ||Not Available |
| ||Float ||9,155,400 ||a/o Apr 30, 2012 |
| ||Par Value ||No Par Value |
MIHI Completes Acquisition of Joint Venture “MEDHOLD”, divests its old business operations.
MIHI is now Laser Focused on Serving the millions of Underserved Patient Population in America. All services are delivered thru a Novel “Virtual Health” system.
Company Plans To Change name to “Medical Innovation Holdings, Inc.”
Duluth, Ga. – __/__/2016 –
Medina Innovation Holdings, Inc. (“MIHI” or the “Company”) (OTC: MIHI) today announced that it has completed an Acquisition and Purchase Agreement with Medical Innovation Holdings, a Joint Venture (“MedHold”) with an effective date of April 29, 2016, whereby all of the assets were acquired by the Company from MedHold.
Medina International Holdings, Inc., (“MIHI” or the “Company”) (OTC: MIHI), changing its’ name to Medical Innovation Holdings, Inc., announces the roll out of a multi-disciplinary medical specialist provider/practice network, focused on serving the needs of underserved patient populations. The practice will be staffed by 16 types of Physician Specialists working in tandem with primary care providers via a seamless, comprehensive, sophisticated telemedicine program.
“Now millions of patients living in rural America with little or no specialty medical services can now have on demand care at their primary care doctor’s office. Teaming with primary doctors provides a comprehensive quality continuum of care by increasing patients’ access to vital services. It is our expectation that by providing early diagnosis prevents the onset of chronic conditions enhancing the quality of lives while saving time and money” says CEO Arturo “Jake” Sanchez.
About Medical Innovation Holdings, Inc.
MIHI, a Colorado-based publicly traded company, owns and operates strategically aligned health care service companies focused on the delivery of clinical virtual medicine (health) as a way of bringing quality medical care to all areas of need including rural and underdeveloped areas across the country. Through our wholly owned subsidiary, 3Point Care, we provide personalized high-tech high-touch telemedicine encounters pairing our virtual health specialty doctors with traditional primary doctors utilizing nextgen virtual health technologies in order to connect a patient with a multi-disciplinary specialty clinical healthcare practice. Through our other companies and relationships we offer Affordable Care Organization (ACO) support, wellness and prevention, lab analysis and lab services, and remote diagnostic monitoring.
Arturo “Jake” Sanchez
Arturo “Jake” Sanchez was appointed CEO in February 2016. Jake is a seasoned executive with extensive skills in operations, technology, P&L oversight, direct and non-direct channel sales and marketing working with both startups and growth organizations. He is a results oriented leader with proven accomplishments in strategic positioning using process driven approach to manage and scale organizations. He comes with a track record of increasing revenue, driving down costs, growing the bottom line while driving up productivity. He has worked extensively in disruptive market opportunities where technology, regulations, and laws create havoc and change in existing markets allowing new players to enter the marketplace.
Mr. Sanchez was founder and Chairman/ CEO of Planning Technologies, Inc. where he developed leadership tactics focused on growth and revenue. PTI was recognized as one of the nation’s premier leading providers of consulting and engineering services. The company grew under Mr. Sanchez’s leadership to include more than 200 employees serving a worldwide client base of Fortune 100 companies and U.S. government agencies. While working with the Veterans Administration Mr. Sanchez and his company designed, developed, integrated, and installed one of the first tele medicine applications for remote heart monitoring and diagnostics.
While at Sunrise Computer Systems in Atlanta, GA., he designed corporate data networks for large hospital systems most notably Piedmont Hospital in Atlanta. He also worked with Wellstar, Georgia Baptist, Emory, and Northside Hospital
Mr. Sanchez has been recognized as one of the nation’s top entrepreneurs. Planning Technologies, Inc. won distinction as the Atlanta Hispanic Chamber of Commerce Hispanic Business of the Year, The Small Business Administration (SBA) Minority/Supplier of the year, the fastest growing Hispanic firm of the year, and The Department of Agriculture Minority Firm of the year. Mr. Sanchez has been recognized as a finalist for the Ernst & Young Entrepreneur of the Year Award and as a member of various High Tech 50 awards for Hispanic Magazine and various other technology publications.
He has served on the boards of the Red Cross, Georgia State Mack Robinson College of Business, Kennesaw State University Foundation executive committee, Charter Bank, One Georgia Bank (advisor) and was governor-appointed to serve on the Georgia Port Authority Board where he became chair of trade development. Mr. Sanchez was also recognized as a Kennesaw State University Fellow and was awarded the prestigious Erwin Zaban Entrepreneurial award by the Foundation.
Mr. Sanchez received his undergraduate degree in Finance and was a four-year letterman in wrestling at Marshall University. He has two sons and enjoys golf and staying healthy.
Interim CFO and Director
Mr. Litowitz’s experience includes over 35 years focusing on entrepreneurial and middle-market companies in a broad range of businesses. He has worked in venture capital, venture capital backed companies and companies with a nationwide footprint. Additionally, he has participated or led 11 IPO transactions. Additionally, he has been the CFO of 3 public companies ranging in size from $25mm to $350mm implementing Sarbox programs and interacting with institutional investors on road shows and investor calls. Mr. Litowitz has also been the CFO of a major Private Equity firm participating in many different financing rounds of all types.
He was the Chief Financial Officer for Galen Partners, a leading venture capital firm with over $400 million under management, specializing in healthcare businesses, including high tech enterprises. These included voice recognition technology, specialized data information and high tech infusion system companies. Total revenue of the portfolio companies was over $800 million. While at Galen, he was a member of numerous boards of portfolio companies of which three were taken public. He was the first employee and he structured the firm’s due diligence as well as its reporting and accounting policies. Mr. Litowitz's responsibilities included acting as mentor and leader to portfolio Chief Financial Officers and was a liaison to many of Galen's investors.
Dr. Christopher JWB Leggett
Chief Medical Officer
Dr. Christopher JWB Leggett is a clinical academic interventional cardiologist. He received his board certifications in internal medicine, cardiology and interventional cardiology through the American Board of Internal Medicine. He presents to us with a lifetime of stellar achievement. A Native of Cleveland, Ohio he was born the tenth of eleven children to Willie and Ethel Leggett. At thirteen years of age, he was awarded a three year academic scholarship by the “A Better Chance” organization to attend Phillips Academy in Andover, Massachusetts. After graduation, he received a four year academic scholarship to attend Princeton University. He graduated with a Bachelor of Arts degree in Sociology in 1982. He was a campus leader and member of the Princeton University basketball team.
His education continued at Case Western Reserve School of Medicine where he received his Doctorate of Medicine in 1986. He completed his internal medicine internship and residency at the world renowned Johns Hopkins Hospital in Baltimore, Maryland. He then completed his cardiology fellowship at Emory University School of Medicine. Immediately following his fellowship he remained on faculty at Emory as an attending in the Cardiac Catheterization Laboratory at the Veterans Administration Hospital of Atlanta. Dr. Leggett was then offered a prestigious interventional cardiology fellowship at the University of Alabama at Birmingham under the tutelage of world leader and pioneer of cardiac stent technology, Dr. Gary Roubin. He was subsequently expertly trained in all aspects of coronary and peripheral endovascular interventions and technology.
Leonard Makowka, M.D., PH.D., FRCS(C), FACS
Strategic Medical Manager
Doctor Makowka was appointed Strategic Medical Manager of Medina International Holdings, Inc. on November 5, 2015. Dr. Makowka earned and received an M.D. in 1977 from the University of Toronto, a Master of Science from the Department of Pathology at the University of Toronto in 1979 and a Doctor of Philosophy in 1982 from the Department of Pathology at the University of Toronto.